← All stocks

ONCOLYTICS BIOTECH INC

ONCY No buying or selling

CIK 0001129928 #4318 in the set updated 19 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

10 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Seizinger Bernd R.

Director

—

566,991

$544.31K

+54.5%

Pisano Wayne

Director

—

492,414

$472.72K

+6.5%

Look Kirk

Chief Financial Officer

—

287,515

$276.01K

+4.4%

Heineman Thomas Charles

Chief Medical Officer

—

282,818

$271.51K

+4.5%

Hagerman Allison

Chief Technology Officer

—

115,059

$110.46K

+9.5%

Kelly Jared

Chief Executive Officer

—

114,050

$109.49K

+54.3%

Brown Deborah Margaret

Director

—

109,851

$105.46K

+29.5%

Andrews Patricia S

Director

—

78,128

$75.00K

+82.8%

Aromando Andrew

Chief Business Officer

—

55,100

$52.90K

+116.1%

Parsons James T.

Director

—

41,849

$40.18K

+31.4%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 20 Jan 2026